This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring both bromo and fluoro substituents, makes it valuable for developing compounds with specific biological activities, particularly in the realm of central nervous system (CNS) drugs. It is often employed in the production of selective serotonin reuptake inhibitors (SSRIs) and other neuroactive agents, where its chiral center plays a critical role in enhancing drug efficacy and reducing side effects. Additionally, it is used in research settings for the development of novel therapeutic agents targeting neurological disorders.